2CUREX vs ASND: Side-by-Side Comparison
Compare 2cureX AB (2CUREX) and Ascendis Pharma A/S (ASND) side by side: market cap SEK 46.39M vs USD 16.96B. Financials, growth and model signals on Bullrun.
| Metric | 2CUREX | ASND |
|---|---|---|
| Company | 2cureX AB | Ascendis Pharma A/S |
| Country / Exchange | Denmark · ST | Denmark · NASDAQ |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Market cap | SEK 46.39M | USD 16.96B |
| P/E ratio | — | 30.9 |
| Dividend yield | — | — |
| Valuation model | — | 85.7% undervalued |
| Revenue (latest FY) | SEK 0 | — |
| Revenue growth YoY | — | — |
| Net income | SEK -4.55M | — |
| Gross margin | — | — |
| Diluted EPS | -0.18 | — |